Related Experiment Video
Updated: Jun 26, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]
K Miller1, L Bergmann, E Jäger
1Klinik für Urologie, Charité-Universitätsmedizin Berlin, Berlin. kurt.miller@charite.de
Abstract:
With the introduction of targeted therapies, a paradigm shift for the treatment of metastatic renal cell cancer has taken place. New compounds like sunitinib, sorafenib, bevacizumab and temsirolimus have become established as new therapeutic standards. An interdisciplinary consensus conference was held to discuss treatment sequences and open questions. Results from the 2007 conference provided the basis for the 2008 meeting. The results of the 2008 conference are presented as short theses.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Acute Kidney Injury V: Interprofessional Care
Treatment Resistent Cancers
